Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The Cardiovascular Risk in Young Finns Study

European Journal of Clinical Investigation

Volumn 41, Issue 9, 2011, Pages 951-957

  Haarala, Atte ^a   Kähönen, Mika ^a,b   Eklund, Carita ^a   Jylhävä, Juulia ^a   Koskinen, Tuomas ^c   Taittonen, Leena ^d,e   Huupponen, Risto ^f,g   Lehtimäki, Terho ^a,b   Viikari, Jorma ^g   Raitakari, Olli T ^c,g   Hurme, Mikko ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e VAASA CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Autonomic nervous system; C reactive protein; Heart rate variability; Inflammation; Leptin; Serum amyloid a

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; LEPTIN; SERUM AMYLOID A;

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; HEART RATE VARIABILITY; HUMAN; INFLAMMATION; MALE; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADULT; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; FINLAND; HEART RATE; HUMANS; LEPTIN; LINEAR MODELS; MALE; RISK ASSESSMENT; RISK FACTORS; SERUM AMYLOID A PROTEIN; YOUNG ADULT;

EID: 79960978026     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02485.x     Document Type: Article

References (33)

1. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurements, physiological interpretation and clinical use. Circulation 1996;93:1043-65.
2. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 2000;102:1239-44.
3. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000;13:112S-22S.
4. Urbancic-Rovan V, Meglic B, Stefanovska A, Bernjak A, Azman-Juvan K, Kocijancic A. Incipient cardiovascular autonomic imbalance revealed by wavelet analysis of heart rate variability in Type 2 diabetic patients. Diabet Med 2007;24:18-26.
5. Mussalo H, Vanninen E, Ikaheimo R, Laitinen T, Laakso M, Lansimies E et al. Heart rate variability and its determinants in patients with severe or mild essential hypertension. Clin Physiol 2001;21:594-604.
6. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-62.
7. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421:384-8.
8. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-9.
9. Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 2008;33:1305-12.
10. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363-70.
11. Sloan RP, Mccreath H, Tracey KJ, Sidney S, Liu K, Seeman T. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 2007;13:178-84.
12. Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med 2009;265:439-47.
13. Lampert R, Bremner JD, Su S, Miller A, Lee F, Cheema F et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008;156:759.e1-7.
14. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
15. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
16. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
17. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Hansen JF. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J Intern Med 2006;260:377-87.
18. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:726-32.
19. Jylhava J, Haarala A, Eklund C, Pertovaara M, Kahonen M, Hutri-Kahonen N et al. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study. J Intern Med 2009;266:286-95.
20. Sjoholm K, Palming J, Olofsson LE, Gummesson A, Svensson PA, Lystig TC et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 2005;90:2233-9.
21. Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 2006;3:e287.
22. Viikari LA, Huupponen RK, Viikari JS, Marniemi J, Eklund C, Hurme M et al. Relationship between leptin and C-reactive protein in young Finnish adults. J Clin Endocrinol Metab 2007;92:4753-8.
23. Paolisso G, Manzella D, Montano N, Gambardella A, Varricchio M. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab 2000;85:1810-4.
24. Akerblom HK, Viikari J, Uhari M, Rasanen L, Byckling T, Louhivuori K et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatr Scand Suppl 1985;318:49-63.
25. Juonala M, Viikari JS, Hutri-Kahonen N, Pietikainen M, Jokinen E, Taittonen L et al. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med 2004;255:457-68.
26. Raitakari OT, Juonala M, Ronnemaa T, Keltikangas-Jarvinen L, Rasanen L, Pietikainen M et al. Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol 2008;37:1220-6.
27. Koskinen T, Kahonen M, Jula A, Laitinen T, Keltikangas-Jarvinen L, Viikari J et al. Short-term heart rate variability in healthy young adults The Cardiovascular Risk in Young Finns Study. Auton Neurosci 2009;145:81-8.
28. Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res 1971;29:437-45.
29. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-93.
30. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
31. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 2007;21:736-45.
32. Koskinen T, Kahonen M, Jula A, Mattsson N, Laitinen T, Keltikangas-Jarvinen L et al. Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study. Diabet Med 2009;26:354-61.
33. O'brien E, Mee F, Atkins N, O'malley K. Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet 1990;336:1465-8.